Ogura M, Yasuno M, Kobayashi Y, Tsukada T
Department of Hematological Laboratory, Toranomon Hospital, Tokyo.
Rinsho Byori. 1995 Apr;43(4):385-90.
Clinical significance of platelet volume indices (Platelet distribution width: PDW, Mean platelet volume: MPV, Platelet large cell ratio: P-LCR) estimated by automated blood cell analyzer (Sysmex NE-8000) was studied in 29 ITP cases and 17 cases with platelet hypoproduction which diagnosis was established by platelet kinetic study, megakaryocyte counts and the amount of platelet-associated IgG. These indices were not obtained by analyzer in 48% of 23 cases with platelet count less than 50 x 10(9)/l and 23% of 31 cases with platelet counts ranged in 50-100 x 10(9)/l. The coefficient of variation (CV) of PDW, MPV and P-LCR estimated 5 times in samples with platelet count more than 100 x 10(9)/l was 2%, 1% and 2.3%, respectively. In samples with platelet count less than 50 x 10(9)/l, CV of each index increased 3 times or more. Only four out of 22 ITP cases with platelet count less than 100 x 10(9)/l showed increased platelet volume and remaining 18 cases showed normal volume. In 12 cases with platelet hypoproduction, 3 cases showed increase of platelet volume and one case showed decrease of volume. Significant correlation was observed in between PDW and platelet survival time (r = -0.41, p < 0.05) and in between PDW and platelet turnover rate (r = 0.38, p < 0.05) in 29 ITP cases. Although the various changes of platelet volume indices during recovery phase after chemotherapy were observed in cases of acute leukemia or malignant lymphoma, these one were not a characteristic change in recovery phase of platelet under-production but rather different in each individual.
通过自动血细胞分析仪(Sysmex NE - 8000)评估的血小板体积指数(血小板分布宽度:PDW、平均血小板体积:MPV、血小板大细胞比率:P - LCR)的临床意义,在29例特发性血小板减少性紫癜(ITP)患者和17例血小板生成减少患者中进行了研究,后者的诊断通过血小板动力学研究、巨核细胞计数以及血小板相关IgG量得以确立。在23例血小板计数低于50×10⁹/L的患者中,48%的病例无法通过分析仪获得这些指数;在31例血小板计数介于50 - 100×10⁹/L的患者中,23%的病例无法获得这些指数。在血小板计数高于100×10⁹/L的样本中,对PDW、MPV和P - LCR进行5次评估的变异系数(CV)分别为2%、1%和2.3%。在血小板计数低于50×10⁹/L的样本中,各指数的CV增加了3倍或更多。在22例血小板计数低于100×10⁹/L的ITP患者中,只有4例显示血小板体积增加,其余18例显示体积正常。在12例血小板生成减少的患者中,3例显示血小板体积增加,1例显示体积减小。在29例ITP患者中,观察到PDW与血小板生存时间之间存在显著相关性(r = -0.41,p < 0.05),以及PDW与血小板周转率之间存在显著相关性(r = 0.38,p < 0.05)。尽管在急性白血病或恶性淋巴瘤病例中观察到化疗后恢复阶段血小板体积指数的各种变化,但这些并非血小板生成减少恢复阶段的特征性变化,而是个体差异较大。